z-logo
open-access-imgOpen Access
[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]
Author(s) -
Elena Galli,
Maria Paola Pedone,
Miryana Dobreva,
Rossella Bitonti,
Roberta Di Turi
Publication year - 2022
Publication title -
farmeconomia health economics and therapeutic pathways
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v23i1.1527
Subject(s) - dupilumab , medicine , atopic dermatitis , quality of life (healthcare) , eczema area and severity index , population , adverse effect , pediatrics , dermatology , environmental health , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom